In addition, the western blot assay presented that METTL3 downregulation mediated the promoting roles in CD31 and VE-cadherin and that the inhibitory roles in vimentin and α-SMA were strikingly reversed by HF or ET-1 treatment (Figure 5(b)). The gene discussed is CDH5; the disease is hydrops fetalis.